{"name": "Avexxin",
 "permalink": "avexxin",
 "crunchbase_url": "http://www.crunchbase.com/company/avexxin",
 "homepage_url": "http://www.avexxin.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "avexxin@avexxin.com",
 "phone_number": "+47 73 59 61 07",
 "description": "",
 "created_at": "Tue Jan 11 02:13:59 UTC 2011",
 "updated_at": "Tue Jan 11 02:13:57 UTC 2011",
 "overview": "\u003Cp\u003EAvexxin\u0026#8217;s therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases at the Norwegian University of Science and Technology. Avexxin\u00e2\u20ac\u2122s goal is to create a therapeutic company based on the discovery and development of novel therapeutics that address the fundamental mechanisms involved in inflammatory diseases. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       54],
      "assets/images/resized/0011/6766/116766v1-max-150x150.png"],
     [[222,
       81],
      "assets/images/resized/0011/6766/116766v1-max-250x250.png"],
     [[222,
       81],
      "assets/images/resized/0011/6766/116766v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Mikael",
      "last_name": "\u00c3\u02dcrum",
      "permalink": "mikael-rum",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/search?q=Avexxin",
    "source_description": "Avexxin Completes Financing Round",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sarsia Seed Management",
         "permalink": "sarsia-seed-management",
         "image":
          {"available_sizes":
            [[[150,
               80],
              "assets/images/resized/0010/3644/103644v2-max-150x150.jpg"],
             [[170,
               91],
              "assets/images/resized/0010/3644/103644v2-max-250x250.jpg"],
             [[170,
               91],
              "assets/images/resized/0010/3644/103644v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Leiv Eiriksson Invest",
         "permalink": "leiv-eiriksson-invest",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Department of Biology",
    "address2": "Norwegian University of Science and Technology",
    "zip_code": "N-7491",
    "city": "H\u00c3\u00b8gskoleringen 5, Trondheim",
    "state_code": null,
    "country_code": "NOR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}